Avendus Future Leaders Fund: the late-stage machine riding India's pre-IPO wave

Avendus's flagship private-strategies fund has backed Lenskart, Delhivery, NSE and Licious, returned over 100% of FLF I's capital in four years, and is raising towards Rs 1,800 crore for FLF III. It buys small, patient, pre-IPO stakes in category leaders.

By the time a startup becomes a household name, the biggest returns have usually already been captured - unless you know where to look. Avendus Future Leaders Fund (FLF), the flagship private-strategies platform of Mumbai-headquartered Avendus Group, exists precisely for that window: late-stage, pre-IPO investments in India's category leaders, in small minority stakes, held patiently to liquidity.

Investment thesis

FLF is a SEBI Category-II AIF that describes itself as a late-stage fund making small minority investments - typically under 5% - in "best in breed" market-leading and emerging category leaders. The sweet spot: moated, dominant market leaders, roughly 2-3 years from a liquidity event, typically valued $800 million-$5 billion. It is a deliberately passive-style co-investor - working with, not against, other PE sponsors - doing primary deals and secondaries, with exits via secondaries and public-market disposals.

Funds, stages and cheque sizes

FLF I (February 2019) raised ~Rs 375 crore and is in harvest, having returned over 100% of investor capital within four years, with ~4x reported on Lenskart and NSE exits. FLF II (August 2021) closed at Rs 1,500 crore in early 2022 after a Rs 584 crore first close, investing Rs 35-100 crore per deal across 8-10 companies. FLF III (May 2024) targeted Rs 3,000 crore (~$350 million) including a green shoe, made a Rs 850 crore first close in January 2025, and was reported in July 2026 to be nearing a ~Rs 1,800 crore final close (guided, not confirmed). Average ticket: Rs 150-300 crore, 12-14 investments planned. Sectors: financial services, consumption, digital and technology, plus healthcare and manufacturing in Fund III.

Notable portfolio

FLF I names: Lenskart Solutions, Delhivery, VerSe Innovation (Dailyhunt/Josh), Bikaji Foods, National Stock Exchange and Ujjivan Small Finance Bank. FLF II: SBI General Insurance, Licious, Zeta, Lenskart, XpressBees, NSE, Indegene, FirstCry, Juspay and Avanse Financial Services. FLF III (deploying): La Renon Healthcare (Rs 160 crore minority stake), Aragen Life Sciences (Rs 300 crore alongside SBI Life), IL JIN Electronics and Parag Parikh Financial Advisory Services (Rs 140 crore secondary).

People

The platform is spearheaded by Ritesh Chandra, Managing Partner of the Future Leaders Fund franchise - verified across Avendus's official releases from 2021 to 2026. The firm's releases describe "a seasoned team" but no other FLF team names could be verified from Avendus's site or credible press, so they are omitted here. Avendus Group was established in 1999 by Ranu Vohra, Gaurav Deepak and Kushal Aggarwal.

Credits and perks

Not applicable - FLF is a late-stage private fund, not an early-stage programme; it runs no accelerator and publishes no startup credits or perks.

How to engage

There is no public application or pitch portal for FLF - engagement is relationship-driven. The fund leans on Avendus's 25+ years of entrepreneur relationships and its investment-banking network for proprietary deal access. Practically, founders reach FLF through bankers, network introductions or their existing PE backers' ties to Avendus. Fit check: companies 2-3 years from liquidity, small minority stakes only - not a control investor, not an early-stage fund.

Why it matters for founders

If you run a late-stage Indian category leader 2-3 years from IPO, FLF is one of the few domestic platforms built for your cap table: patient, minority, PE-friendly, with FLF I returning 100%+ of capital in four years and live Rs 150-300 crore cheques from FLF III. The catch is access - no form to fill, so build the Avendus relationship well before you need the money.